Literature DB >> 16802351

The heritable determinants of cartilage oligomeric matrix protein.

Frances M K Williams1, Toby Andrew, Tore Saxne, Dick Heinegard, Tim D Spector, Alex J MacGregor.   

Abstract

OBJECTIVE: Cartilage oligomeric matrix protein (COMP) is a cartilage matrix macromolecule. The protein is detectable in serum and has been investigated as a biomarker of osteoarthritis (OA). An association between COMP and OA has been shown, yet the precise factors governing serum levels of COMP remain unclear. The aim of this study was to determine whether genetic factors influence serum levels of COMP.
METHODS: A classic twin study was conducted using COMP levels in serum obtained from healthy female twin volunteers. COMP levels were determined by an inhibition enzyme-linked immunosorbent assay method. The heritability of COMP was determined by comparing correlation among 160 monozygotic and 349 dizygotic twin pairs. Data on potential confounding factors, including age, body mass index, and the presence of OA as assessed by hand, hip, and knee radiographs, were included in the analysis.
RESULTS: Serum levels of COMP showed a correlation of 0.72 (95% confidence interval [95% CI] 0.65-0.80) among monozygotic twin pairs and 0.47 (95% CI 0.39-0.55) in dizygotic pairs. This equated to an estimated heritability for COMP of 40% (95% CI 20-60%). Although age and body mass index were found to be significantly associated with COMP in regression analysis, taking the effects of these factors into account did not influence the estimate of heritability.
CONCLUSION: This study showed that heritable factors influence serum levels of the cartilage matrix biomarker COMP. Together with other published data, the results suggest that genetic factors operate at an early stage in the etiologic pathways that influence the development of radiographically discernible OA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802351     DOI: 10.1002/art.21931

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

1.  Genome-wide linkage analysis of quantitative biomarker traits of osteoarthritis in a large, multigenerational extended family.

Authors:  Hsiang-Cheng Chen; Virginia Byers Kraus; Yi-Ju Li; Sarah Nelson; Carol Haynes; Jessica Johnson; Thomas Stabler; Elizabeth R Hauser; Simon G Gregory; William E Kraus; Svati H Shah
Journal:  Arthritis Rheum       Date:  2010-03

2.  Biomarkers in osteoarthritis.

Authors:  Frances M K Williams; Tim D Spector
Journal:  Arthritis Res Ther       Date:  2008-01-16       Impact factor: 5.156

Review 3.  The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

Authors:  Josef S Smolen; Daniel Aletaha; Johannes Grisar; Kurt Redlich; Günter Steiner; Oswald Wagner
Journal:  Arthritis Res Ther       Date:  2008-05-29       Impact factor: 5.156

4.  Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Authors:  Maria L E Andersson; Björn Svensson; Ingemar F Petersson; Ingiäld Hafström; Kristina Albertsson; Kristina Forslind; Dick Heinegård; Tore Saxne
Journal:  BMC Musculoskelet Disord       Date:  2013-08-02       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.